Screener
Axogen AXGN Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Axogen in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Axogen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000805928-26-000094
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 48,606 | 92,840 |
| Commitments and contingencies - see Note 14 | ||
| Shareholders’ equity | ||
| Common stock, $0.01 par value per share; 100,000,000 shares authorized; 53,656,293 and 47,199,797 shares issued and outstanding, respectively | 537 | 472 |
| Additional paid-in capital | 583,783 | 435,338 |
| Accumulated deficit | (328,063) | (306,963) |
| Total shareholders’ equity | 256,257 | 128,847 |
| Total liabilities and shareholders’ equity | $304,863 | $221,687 |
ITEM 1 — FINANCIAL STATEMENTS
FAQ
- What is Axogen's common stock, par value (in dollars per share)?
- Axogen (AXGN) reported common stock, par value (in dollars per share) of $0.01 in Q2 2026.
- How has Axogen's common stock, par value (in dollars per share) changed year-over-year?
- Axogen's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0.01 to $0.01.
- What is the long-term trend for Axogen's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Axogen's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.
Ask your AI about Axogen's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude